Contact
Please use this form to send email to PR contact of this press release:
IntelGenx Provides Update on RIZAPORT® VersaFilm® NDA Resubmission Process Following Type A Meeting with the FDA
TO:
Please use this form to send email to PR contact of this press release:
IntelGenx Provides Update on RIZAPORT® VersaFilm® NDA Resubmission Process Following Type A Meeting with the FDA
TO: